Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides: Impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity.

Solans-Laqué R, Fraile G, Rodriguez-Carballeira M, Caminal L, Castillo MJ, Martínez-Valle F, Sáez L, Rios JJ, Solanich X, Oristrell J, Pasquau F, Fonseca E, Zamora M, Callejas JL, Frutos B, Abdilla M, Fanlo P, García-Sánchez I, López-Dupla M, Sopeña B, Pérez-Iglesias A, Bosch JA; Spanish Registry of systemic vasculitis (REVAS) from the Autoimmune Diseases Study Group (GEAS) of the Spanish Society of Internal Medicine (SEMI).

Medicine (Baltimore). 2017 Feb;96(8):e6083. doi: 10.1097/MD.0000000000006083.

2.

Off-label use of rituximab for systemic lupus erythematosus in Europe.

Rydén-Aulin M, Boumpas D, Bultink I, Callejas Rubio JL, Caminal-Montero L, Castro A, Colodro Ruiz A, Doria A, Dörner T, Gonzalez-Echavarri C, Gremese E, Houssiau FA, Huizinga T, Inanç M, Isenberg D, Iuliano A, Jacobsen S, Jimenéz-Alonso J, Kovács L, Mariette X, Mosca M, Nived O, Oristrell J, Ramos-Casals M, Rascón J, Ruiz-Irastorza G, Sáez-Comet L, Salvador Cervelló G, Sebastiani GD, Squatrito D, Szücs G, Voskuyl A, van Vollenhoven R.

Lupus Sci Med. 2016 Sep 6;3(1):e000163. doi: 10.1136/lupus-2016-000163. eCollection 2016.

3.

Safety and effectiveness of outpatient parenteral antimicrobial therapy in older people.

Mujal A, Sola J, Hernandez M, Villarino MA, Baylina M, Tajan J, Oristrell J.

J Antimicrob Chemother. 2016 May;71(5):1402-7. doi: 10.1093/jac/dkv478. Epub 2016 Jan 31.

PMID:
26832749
4.

Safety and effectiveness of home intravenous antibiotic therapy for multidrug-resistant bacterial infections.

Mujal A, Sola J, Hernandez M, Villarino MA, Machado ML, Baylina M, Tajan J, Oristrell J.

Eur J Clin Microbiol Infect Dis. 2015 Jun;34(6):1125-33. doi: 10.1007/s10096-015-2330-0. Epub 2015 Feb 6.

PMID:
25655757
5.

The PREDICT (increasing the participation of the elderly in clinical trials) study: the charter and beyond.

Crome P, Cherubini A, Oristrell J.

Expert Rev Clin Pharmacol. 2014 Jul;7(4):457-68. doi: 10.1586/17512433.2014.922864. Review.

PMID:
24939469
6.

The Computer Book of the Internal Medicine Resident: competence acquisition and achievement of learning objectives.

Oristrell J, Oliva JC, Casanovas A, Comet R, Jordana R, Navarro M.

Rev Clin Esp (Barc). 2014 Jan-Feb;214(1):8-16. doi: 10.1016/j.rce.2013.07.010. Epub 2013 Sep 13. English, Spanish.

PMID:
24035662
7.

[The Computer Book of the Internal Medicine resident: validity and reliability of a questionnaire for self-assessment of competences in internal medicine residents].

Oristrell J, Casanovas A, Jordana R, Comet R, Gil M, Oliva JC; equipo de residentes de Medicina Interna de la Corporació Sanitària i Universitària Parc Taulí.

Rev Clin Esp. 2012 Dec;212(11):520-37. doi: 10.1016/j.rce.2012.04.004. Epub 2012 Jun 7. Spanish.

PMID:
22683030
8.

Exclusion of older people from clinical trials: professional views from nine European countries participating in the PREDICT study.

Crome P, Lally F, Cherubini A, Oristrell J, Beswick AD, Clarfield AM, Hertogh C, Lesauskaite V, Prada GI, Szczerbińska K, Topinkova E, Sinclair-Cohen J, Edbrooke D, Mills G.

Drugs Aging. 2011 Aug 1;28(8):667-77. doi: 10.2165/11591990-000000000-00000.

PMID:
21812501
9.

Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label.

Díaz-Lagares C, Pérez-Alvarez R, García-Hernández FJ, Ayala-Gutiérrez MM, Callejas JL, Martínez-Berriotxoa A, Rascón J, Caminal-Montero L, Selva-O'Callaghan A, Oristrell J, Hidalgo C, Gómez-de-la-Torre R, Sáez L, Canora-Lebrato J, Camps MT, Ortego-Centeno N, Castillo-Palma MJ, Ramos-Casals M; BIOGEAS Study Group.

Arthritis Res Ther. 2011 Jul 11;13(4):R112. doi: 10.1186/ar3397.

10.

The persistent exclusion of older patients from ongoing clinical trials regarding heart failure.

Cherubini A, Oristrell J, Pla X, Ruggiero C, Ferretti R, Diestre G, Clarfield AM, Crome P, Hertogh C, Lesauskaite V, Prada GI, Szczerbinska K, Topinkova E, Sinclair-Cohen J, Edbrooke D, Mills GH.

Arch Intern Med. 2011 Mar 28;171(6):550-6. doi: 10.1001/archinternmed.2011.31.

PMID:
21444844
11.

Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases.

Ramos-Casals M, García-Hernández FJ, de Ramón E, Callejas JL, Martínez-Berriotxoa A, Pallarés L, Caminal-Montero L, Selva-O'Callaghan A, Oristrell J, Hidalgo C, Pérez-Alvarez R, Micó ML, Medrano F, Gómez de la Torre R, Díaz-Lagares C, Camps M, Ortego N, Sánchez-Román J; BIOGEAS Study Group.

Clin Exp Rheumatol. 2010 Jul-Aug;28(4):468-76. Epub 2010 Aug 30.

PMID:
20525449
12.

Analysis of temporal artery biopsies in an 18-year period at a community hospital.

Marí B, Monteagudo M, Bustamante E, Pérez J, Casanovas A, Jordana R, Tolosa C, Oristrell J.

Eur J Intern Med. 2009 Sep;20(5):533-6. doi: 10.1016/j.ejim.2009.05.002. Epub 2009 Jun 3.

PMID:
19712860
13.

Effectiveness of rituximab in severe Wegener's granulomatosis: report of two cases and review of the literature.

Oristrell J, Bejarano G, Jordana R, Monteagudo M, Marí B, Casanovas A, Tolosa C.

Open Respir Med J. 2009 Jun 25;3:94-9. doi: 10.2174/1874306400903010094.

14.

Plasma interleukin-6 levels in Mediterranean spotted fever.

Oristrell J, Sampere M, Amengual MJ, Font B, Segura F.

Eur J Clin Microbiol Infect Dis. 2004 May;23(5):417-8. Epub 2004 Apr 22. No abstract available.

PMID:
15103526
15.

[Type II essential mixed cryoglobulinemia and renal disease. Hepatitis C virus association].

Almirall J, Amengual MJ, López T, Andreu X, Oristrell J, Sala M, Luelmo J, Dalmau B.

Nefrologia. 2002;22(6):531-9. Spanish.

16.

Diffuse non-hydrostatic, non-hypooncotic edema in autoimmune lupus-like disorders.

Oristrell J, Pujol R, Bosque M, Moga MI, Amengual MJ, Chivite D, Casanovas A, Mitjavila F, de Nadal J.

Am J Med. 2001 Apr 15;110(6):492-5. No abstract available.

PMID:
11331063
17.

Circulating soluble adhesion molecules in patients with giant cell arteritis. Correlation between soluble intercellular adhesion molecule-1 (sICAM-1) concentrations and disease activity.

Coll-Vinent B, Vilardell C, Font C, Oristrell J, Hernández-Rodríguez J, Yagüe J, Urbano-Márquez A, Grau JM, Cid MC.

Ann Rheum Dis. 1999 Mar;58(3):189-92.

18.

[A 17-year-old woman with fever and cervical adenopathies (clinico-pathologic conference)].

Oristrell J, Miquel R.

Med Clin (Barc). 1999 Mar 27;112(11):428-35. Spanish. No abstract available.

PMID:
10231777
19.

[Multiple cerebral abscesses with spontaneous emptying into the ventricles and a good response to meropenem].

Font-Rocabayera J, Oristrell J, Font B, Segura-Porta F.

Enferm Infecc Microbiol Clin. 1998 Jun-Jul;16(6):293-4. Spanish. No abstract available.

PMID:
9763753
20.

Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis.

Cid MC, Font C, Oristrell J, de la Sierra A, Coll-Vinent B, López-Soto A, Vilaseca J, Urbano-Márquez A, Grau JM.

Arthritis Rheum. 1998 Jan;41(1):26-32.

PMID:
9433866

Supplemental Content

Loading ...
Support Center